Eaton Vance Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $44.5M | Buy |
180,971
+81,234
| +81% | +$24.7M | 0.07% | 286 |
|
|
2022
Q2 | $30.2M | Sell |
99,737
-1,149
| -1% | -$374K | 0.04% | 376 |
|
|
2022
Q1 | $41.4M | Buy |
100,886
+30,532
| +43% | +$12M | 0.05% | 348 |
|
|
2021
Q4 | $33M | Buy |
70,354
+992
| +1% | +$427K | 0.04% | 380 |
|
|
2021
Q3 | $28.8M | Buy |
69,362
+2,666
| +4% | +$1.12M | 0.04% | 366 |
|
|
2021
Q2 | $23.9M | Buy |
66,696
+5,879
| +10% | +$1.94M | 0.03% | 417 |
|
|
2021
Q1 | $17.1M | Buy |
60,817
+2,142
| +4% | +$613K | 0.03% | 462 |
|
|
2020
Q4 | $16.6M | Buy |
58,675
+2,436
| +4% | +$684K | 0.03% | 446 |
|
|
2020
Q3 | $15.5M | Buy |
56,239
+1,636
| +3% | +$433K | 0.03% | 409 |
|
|
2020
Q2 | $12.4M | Buy |
54,603
+3,280
| +6% | +$644K | 0.03% | 413 |
|
|
2020
Q1 | $7.81M | Sell |
51,323
-3,253
| -6% | -$501K | 0.02% | 461 |
|
|
2019
Q4 | $8.2M | Sell |
54,576
-27
| -0% | -$3.93K | 0.02% | 501 |
|
|
2019
Q3 | $7.74M | Sell |
54,603
-49,690
| -48% | -$6.84M | 0.02% | 499 |
|
|
2019
Q2 | $13.1M | Sell |
104,293
-14,788
| -12% | -$1.75M | 0.03% | 382 |
|
|
2019
Q1 | $13.1M | Sell |
119,081
-116,461
| -49% | -$12.1M | 0.03% | 359 |
|
|
2018
Q4 | $23.1M | Sell |
235,542
-30,316
| -11% | -$3.29M | 0.06% | 250 |
|
|
2018
Q3 | $32.8M | Sell |
265,858
-6,067
| -2% | -$680K | 0.07% | 229 |
|
|
2018
Q2 | $27M | Sell |
271,925
-323,717
| -54% | -$29.8M | 0.06% | 247 |
|
|
2018
Q1 | $52.6M | Buy |
595,642
+307,411
| +107% | +$28.8M | 0.07% | 242 |
|
|
2017
Q4 | $28.4M | Sell |
288,231
-14,314
| -5% | -$1.4M | 0.07% | 233 |
|
|
2017
Q3 | $29.1M | Sell |
302,545
-6,183
| -2% | -$559K | 0.08% | 219 |
|
|
2017
Q2 | $29.2M | Buy |
308,728
+17,512
| +6% | +$1.61M | 0.08% | 216 |
|
|
2017
Q1 | $23.8M | Buy |
291,216
+102,473
| +54% | +$8.57M | 0.06% | 230 |
|
|
2016
Q4 | $16M | Buy |
188,743
+5,352
| +3% | +$421K | 0.05% | 258 |
|
|
2016
Q3 | $13.7M | Sell |
183,391
-80,409
| -30% | -$6.38M | 0.04% | 264 |
|
|
2016
Q2 | $20M | Sell |
263,800
-103,851
| -28% | -$7.56M | 0.06% | 222 |
|
|
2016
Q1 | $25.5M | Sell |
367,651
-738
| -0.2% | -$44.4K | 0.08% | 193 |
|
|
2015
Q4 | $22.2M | Sell |
368,389
-8,098
| -2% | -$487K | 0.07% | 209 |
|
|
2015
Q3 | $20.4M | Sell |
376,487
-18,540
| -5% | -$1.08M | 0.06% | 221 |
|
|
2015
Q2 | $22.9M | Sell |
395,027
-28,195
| -7% | -$1.57M | 0.07% | 212 |
|
|
2015
Q1 | $25.5M | Sell |
423,222
-10,164
| -2% | -$542K | 0.08% | 194 |
|
|
2014
Q4 | $23.1M | Sell |
433,386
-22,987
| -5% | -$1.15M | 0.07% | 208 |
|
|
2014
Q3 | $20.4M | Buy |
456,373
+7,134
| +2% | +$303K | 0.06% | 221 |
|
|
2014
Q2 | $18.9M | Buy |
449,239
+411,687
| +1,096% | +$17.6M | 0.06% | 227 |
|
|
2014
Q1 | $1.65M | Sell |
37,552
-11,961
| -24% | -$563K | ﹤0.01% | 568 |
|
|
2013
Q4 | $2.43M | Sell |
49,513
-36,724
| -43% | -$1.72M | 0.01% | 492 |
|
|
2013
Q3 | $3.55M | Sell |
86,237
-985
| -1% | -$37.6K | 0.01% | 415 |
|
|
2013
Q2 | $3.06M | Buy |
+87,222
| New | +$2.87M | 0.01% | 417 |
|
Other funds holding WST
Eaton Vance Management's WST Position: Q3 2022 in Review
Eaton Vance Management increased its West Pharmaceutical (WST) stake by 81% in Q3 2022, buying an estimated $24.7M and bringing the position to 180,971 shares worth $44.5M. The position accounts for 0.07% of the portfolio, ranked #286.
Eaton Vance Management first reported a position in WST in Q2 2013 and has held it in 38 quarters since. The position peaked at $52.6M in Q1 2018. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.
- Eaton Vance Management held 180,971 shares of West Pharmaceutical worth $44.5M as of Q3 2022.
- Eaton Vance Management bought 81,234 West Pharmaceutical shares in Q3 2022, an estimated $24.7M.
- West Pharmaceutical made up 0.07% of Eaton Vance Management's portfolio in Q3 2022, its #286 holding.
- Eaton Vance Management first reported a position in West Pharmaceutical in Q2 2013 and has held it in 38 quarters since.
- Eaton Vance Management's West Pharmaceutical position peaked at $52.6M in Q1 2018.
- 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.